Chapter 10: New dimensions in cervical cancer screening.
about
Role of human papillomaviruses in carcinogenesisClinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) studyHPV genotype distribution in Brazilian women with and without cervical lesions: correlation to cytological dataNew paradigms in cervical cancer prevention: opportunities and risks.Hybrid capture vs. PCR screening of cervical human papilloma virus infections. Cytological and histological associations in 1270 womenPrognostic value of HPV E6/E7 mRNA assay in women with negative colposcopy or CIN1 histology result: a follow-up study.Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.A survey of population-based utility scores for cervical cancer preventionSensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA testShould LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath specimens with review of literature.Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.Perceptions and Experiences of Human Papillomavirus (HPV) Infection and Testing among Low-Income Mexican Women.New insights into cervical cancer screening.Validation of Serological Antibody Profiles Against Human Papillomavirus Type 16 Antigens as Markers for Early Detection of Cervical Cancer.Beliefs, perceptions and health-seeking behaviours in relation to cervical cancer: a qualitative study among women in Uganda following completion of an HPV vaccination campaign.HPV and cervical cancer: screening or vaccination?Public awareness that HPV is a risk factor for cervical cancer.Invited commentary: is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening?HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.Vaccines against human papillomavirus: perspectives for controlling cervical cancer.Cervical cancer prevention--cervical screening: science in evolution.RNA (E6 and E7) assays versus DNA (E6 and E7) assays for risk evaluation for women infected with human papillomavirus.Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.Human papillomavirus vaccines and vaccine implementation.Trade-offs in cervical cancer prevention: balancing benefits and risks.Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway.HPV E6/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women.Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population.HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women.Use of the HPV MLPA assay in cervical cytology for the prediction of high grade lesions.Is human papillomavirus screening preferable to current policies in vaccinated and unvaccinated women? A cost-effectiveness analysis.
P2860
Q22305628-48C6D1C0-2DFF-42DE-99F2-35ED975DB7ABQ30651813-44011558-0512-425E-AAB0-A75CA0E55994Q31121182-E4DADE83-7C32-4007-931E-9810CE1E385BQ33394011-1E092AE7-EB62-4A27-A7DF-F166840CCBC5Q33533452-2BDFE3D8-ABBD-4AA0-BD3E-3714EF87B3FCQ34608714-B5EBA313-40BE-4152-91EB-2CDBCDF903E1Q34997604-737E5AC9-09CB-464F-B8D6-ED25758DEA80Q35018648-E66AAED8-9D1D-4791-B054-E190E86E408DQ35140046-F31712F5-DD95-45C2-AE8A-69177A0B62C6Q35748537-20AA4FC1-A67A-406D-BEF2-0D502D2038E9Q35927132-B8A0F1E7-FB26-402E-8D0B-556B6FD5AC4BQ36009719-3B36BC89-0A2D-406E-AD7C-D104C579AEB3Q36313296-00A466B4-C817-4318-B73C-CFDE416B386AQ36581107-A0015542-9989-4C8C-8EDB-C59A18EC7D91Q36596319-D98BB404-3202-41A4-A804-02567751F1C0Q36608826-8AF7EEC3-EB59-4409-845A-DDAF03C30CBBQ36611037-A7B740A5-9B7B-4433-BC5C-015D5AF4AB8BQ36743797-82DA95C5-640B-4D9D-8CFD-D35CF8BF5B31Q36830943-A232B984-25C8-404D-BEF8-34C3B6A5F1B2Q36899058-9CEA3442-CD10-4685-9649-D4321932260CQ37025594-42A5D5E0-4D4B-46B4-9423-E2ADF44ACCC3Q37256248-05B117C7-18E8-44B7-8066-DA19746048A8Q37281729-DAC640F3-518E-4306-BCBD-F9BF49A38B01Q37346095-823E2689-1A68-4F73-A4F4-FD2F40B1A369Q37352821-057E9A20-5625-462F-A60B-159ABCCBA188Q40096086-38114E1E-6DC8-4D88-A058-922311955B4AQ41328485-C6ED75FA-30AD-49E4-B347-65AB687AC708Q47159754-CC5A1BA9-97BD-435F-B924-DDB200017CD8Q47848929-B08CB364-AA0A-4B25-AB67-7FD1FA20000DQ50739035-0F38E57A-C6C9-4C52-AA1D-C447FAAEB0E3Q53290879-182C299C-7DCE-4041-8978-5BF9C2581FD9
P2860
Chapter 10: New dimensions in cervical cancer screening.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Chapter 10: New dimensions in cervical cancer screening.
@ast
Chapter 10: New dimensions in cervical cancer screening.
@en
type
label
Chapter 10: New dimensions in cervical cancer screening.
@ast
Chapter 10: New dimensions in cervical cancer screening.
@en
prefLabel
Chapter 10: New dimensions in cervical cancer screening.
@ast
Chapter 10: New dimensions in cervical cancer screening.
@en
P2093
P1433
P1476
Chapter 10: New dimensions in cervical cancer screening.
@en
P2093
Guglielmo Ronco
Jack Cuzick
Jane Wardle
Marie Helene Mayrand
Peter Snijders
P304
P356
10.1016/J.VACCINE.2006.05.122
P407
P478
24 Suppl 3
P577
2006-06-23T00:00:00Z